Cellulite is a common skin condition caused by an accumulation of fat cells pushing up against the skin. This buildup creates a dimpling effect on the surface. Although weight gain can contribute to cellulite development, the condition does not only effect heavier individuals. Cellulite impacts 80 to 90% of women regardless of Body Mass Index (BMI), and anyone can be susceptible to its effects.
Fortunately, you do have options if you struggle with stubborn cellulite and want to make corrections. Cosmetic surgery offers numerous cellulite reduction options from creams to surgeries, each varying in their effectiveness. QWO injections, which are FDA approved and no more invasive than Botox, are the latest of these remedies. Many people wonder: how does QWO differ from other cellulite treatments? A knowledgeable plastic surgeon could answer this question and help you determine the best procedure for your circumstances.
Collagenase clostridium histolyticum-aaes, commonly known as QWO, combines two bacterial-produced enzymes that break down connective tissue at a cellular level. This effective cellulite treatment eradicates the regions that anchor skin to muscle, thus removing pockets of accumulated fat tissue.
QWO is the first and only FDA-approved injectable designed to treat moderate to severe cellulite in the buttocks of adult women. Although these purified collagenolytic enzymes are new to the cosmetic industry, other fields have used QWO for over a decade to treat various connective tissue disorders.
A seasoned cosmetic physician could further outline the basics of QWO injections to help a prospective patient understand the treatment.
Since cellulite results from collagen tethering skin to muscle, effective reduction methods sever these connections. The most popular cellulite reduction procedures use either mechanical blades or thermal laser methods. Both of these options require small incisions to access the tether points. QWO differs from the most historically popular treatments by chemically breaking down connective tissue via the injection of collagenolytic enzymes.
A diligent plastic surgeon could explain the differences between QWO and other methods in more detail to help someone determine which is best for their situation.
Statistical evidence demonstrates that QWO was well tolerated by study participants with no increased risk of adverse reactions over multiple sessions. Additionally, the treatment is less invasive and requires minimal downtime, compared to its traditional counterparts. This means that the injectable has a distinct edge over procedures that require lasers or larger injections.
In one study, women received Collagenase clostridium histolyticum-aaes injections spaced evenly over 90 days. Patients observed a significant reduction in cellulite, making them more confident in their appearance. However, prospective patients should understand that currently, scientists have only reviewed QWO efficacy in the buttocks of adult women. Regardless, the injection is powerful. A dedicated physician could outline the full impact of QWO treatment during a consultation.
The cosmetic industry offers numerous methods of reducing cellulite development, but only one stands out as minimally invasive and less time-consuming. QWO is the first procedure to combat cellulite at its source, using enzymes to release connective tissue. This distinct difference between QWO injections and other cellulite treatments allows patients to return to normal activities immediately following their appointment.
If you are interested in eradicating stubborn cellulite that does not respond to diet and exercise, a detail-oriented plastic surgeon could help you understand how QWO differs from other options. Contact us today to schedule your initial appointment.
Layton Aesthetic Plastic Surgery